CATEGORY

November 17, 2026

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

– REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinically meaningful reduction in risk of death by 41% with median overall survival of 24.0 months versus 14.7 months for best available treatment, and a hazard ratio of 0.59 (p=0.035) – – Company plans to meet with the U.S. Food and Drug […]

CONTINUE READING...

Digital Realty Innovation Lab (DRIL) Launches in Singapore, Enabling Asia Pacific Enterprises to Validate and Scale AI-Ready Infrastructure

SINGAPORE, Nov. 17, 2026 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced the opening of the Digital Realty Innovation Lab (DRIL) in Singapore. The facility provides enterprises across Asia Pacific with a real-world colocation environment inside a live data center to test, validate, and optimize […]

CONTINUE READING...